查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2052063

針頭安全裝置市場－市場趨勢、競爭格局與市場預測（2034 年）

Needle Safety Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

針頭安全裝置市場概述

  • 全球針頭安全裝置市場預計將從 2025 年的 228415 億美元成長到 2034 年的 363749 億美元，展現出強勁且持續的成長勢頭。
  • 全球針頭安全裝置市場預計在 2026 年至 2034 年的預測期內將以 5.39% 的年複合成長率成長。
  • 針頭安全裝置市場成長的主要促進因素是意外針刺傷事件的增加以及醫護人員對血液傳染感染疾病日益成長的擔憂。此外，慢性病患者需要反覆注射，加上免疫接種工作的擴展和醫療成本的上升，也進一步推動了市場擴張。同時，居家醫療和注射療法的自我管理模式的普及，也使得對更安全裝置的需求日益成長。被動式和自動化儲存技術的不斷創新，也提高了安全性、易用性和合規性，從而推動了整體市場成長。
  • 在針頭安全裝置市場營運的主要公司包括 BD、Terumo Corporation、Nipro、ICU Medical、B.Braun、Retractable Technologies、AdvaCare Pharma、Medtronic、Hindustan Syringes & Medical Devices Ltd.、Cardinal Health、Vygon SA、Gerresheimer AG、West Pharmacetical (KDL) Meditech、Weigao Group、江蘇吉春醫療器材有限公司和 Sarstedt AG & CO. KG。
  • 由於北美地區對醫療機構中針刺傷的嚴重性以及降低感染風險的重要性，預計該地區仍將是全球針頭安全裝置市場的重要地區。嚴格的安全法規和職場保護政策促進了安全注射裝置的廣泛應用。慢性疾病患者數量的增加、疫苗接種計劃的擴大以及家庭醫療保健的普及也推動了市場需求。此外，自動化防護和針頭儲存技術的不斷改進提高了安全性，並支撐了該地區市場的穩定成長。
  • 在針頭安全裝置市場的產品類型細分市場中，預計到 2025 年，安全皮下注射針類別將佔據最大的市場佔有率。

推動針頭安全裝置市場成長的因素

  • 針刺傷事件的增加：在醫療機構中，意外銳器傷仍然是嚴重的職業危害，而針刺傷事件的不斷增加正顯著推動針頭安全裝置市場的成長。針刺傷使醫護人員暴露於愛滋病毒、B型肝炎和C型肝炎等血源性病原體，導致嚴重的健康風險、心理壓力和醫療成本增加。疫苗接種、慢性病管理和緊急醫療照護中注射量的增加，使得醫護人員每天接觸針頭的機會也隨之增加。因此，醫療機構正優先採用內建防護功能的安全裝置，以減少意外暴露。這種對預防和風險管理的日益重視，正在全球範圍內創造對針頭安全技術的強勁且持續的需求。
  • 糖尿病、癌症和自體免疫疾病等需要頻繁注射的慢性疾病日益普遍，顯著推動了針頭安全裝置市場的成長。這是因為這些疾病通常需要長期反覆注射治療。接受自體免疫治療、化療、生物製藥製劑或荷爾蒙療法的患者需要在醫院、專科診所和居家照護機構頻繁注射。尤其是在糖尿病和自體免疫疾病中，隨著自我注射治療的日益普及，人們對更安全、更易用的注射裝置的需求也日益成長，以最大限度地減少意外傷害。此外，老年人口的成長以及慢性疾病盛行率的上升也導致全球注射次數的增加。注射治療的持續成長催生了對先進安全注射器和針頭保護技術的強勁需求，進而推動了整個市場的擴張。
  • 免疫接種和疫苗接種計劃的擴展：免疫接種和疫苗接種計劃的成長是針頭安全裝置市場的主要驅動力。大規模疫苗接種活動需要安全可靠的注射技術。政府主導的公共衛生舉措、常規的兒童免疫接種計劃以及針對感染疾病的大規模免疫接種宣傳活動顯著增加了全球注射量。這種高頻率的使用導致對安全注射器和自動失效裝置的需求強勁，以防止針頭重複使用和交叉感染。此外，開發中地區疫苗接種率的提高以及全球為應對新興感染疾病疫情所做的努力，進一步促進了對以安全為設計理念的注射產品的採購。因此，免疫接種計劃的不斷擴大持續為醫療保健系統帶來對針頭安全裝置的穩定需求。
  • 隨著越來越多的患者選擇在傳統醫院之外管理長期疾病，自行注射和居家醫療居家醫療的普及成為針頭安全裝置市場的主要驅動力。糖尿病、自體免疫疾病、荷爾蒙缺乏症和其他慢性疾病的治療通常需要定期注射，因此患者在家中使用胰島素筆、預填充式注射器和生物製藥。這種對便利、經濟的護理方式的追求，推動了對能夠最大限度減少意外傷害、易於使用、可靠且安全的注射裝置的需求。此外，人口老化、門診治療的普及以及藥物輸送系統的進步，進一步加速了安全增強型針頭和筆式裝置在家庭環境中的應用，從而促進了這些市場的持續成長。
  • 產品研發活動增加：隨著製造商致力於開發更有效率、更便捷、更符合法規要求的安全解決方案，產品研發活動的增加正顯著推動針頭安全裝置市場的成長。各公司正加大研發投入，設計出符合人體工學、防護機制更完善、整合安全技術更先進、故障率更低的創新裝置。被動式安全系統、適用於居家醫療保健的緊湊型設計以及與預填充式注射器和生物製藥的兼容性等趨勢，進一步加速了創新進程。此外，下一代產品的合作研究、策略夥伴關係以及監管核准，都在拓展產品系列，增強競爭優勢。這些持續的進步正在提高臨床效率，加速產品在所有醫療機構中的應用，並最終促進整個市場的擴張。

針頭安全裝置市場報告細分

本針頭安全裝置市場報告全面概​​述了全球針頭安全裝置市場，重點分析了關鍵趨勢、成長要素、挑戰和機會。報告按產品類型（針頭安全裝置{安全皮下注射針、安全注射筆針、安全採血針等}、安全靜脈導管、安全注射器）、安全機制（主動和被動安全裝置）、終端用戶（醫院和診所、門診手術中心、居家醫療機構等）以及地區進行了詳細的市場細分。報告深入分析了北美、歐洲和亞太等主要市場的競爭格局、監管環境和市場動態，並詳細介紹了主要行業參與者和近期產品創新，為企業提供關鍵數據，以識別市場潛力、制定戰略規劃並把握快速成長的針頭安全裝置市場中的新興機遇。

針頭安全裝置是醫療設備，其內建保護機制旨在降低使用針頭期間和之後發生意外針刺傷的風險。這些裝置包含多種安全功能，例如伸縮式針頭、滑動護罩、保護鞘套或自動鎖定系統，這些系統可在使用後立即覆蓋或縮回針頭。

全球針頭安全裝置市場受多種相互關聯的因素驅動，這些因素共同推動了全球醫療保健系統對相關產品的應用。其中一個主要促進因素是醫護人員針刺傷發生率的上升。醫院和臨床檢查室越來越重視職業安全，以降低愛滋病毒和肝炎等血液傳播疾病的風險。此外，手術、疫苗接種和慢性病治療數量的增加也是成長要素。隨著糖尿病、癌症和心血管疾病的盛行率上升，注射、靜脈輸液和抽血的頻率也在增加，從而提高了對更安全針頭技術的需求。

技術進步正進一步推動市場擴張。製造商們正在推出被動安全機制、自回縮注射器和人性化設計，這些措施在提高效率的同時，最大限度地減少了人工干預。這些創新提高了產品的可靠性，並促進了醫療機構的更廣泛應用。

總體而言，這些因素正在推動全球針頭安全裝置市場的持續成長，它們將監管合規、技術創新和職業安全優先事項與不斷成長的醫療需求相結合。

針頭安全裝置市場的最新市場動態和趨勢是什麼？

由於醫護人員針刺傷事件的增加以及對血液傳播感染疾病的擔憂，針頭安全裝置市場不斷成長。慢性病盛行率的上升、疫苗接種計劃的擴大、醫療保健支出的增加以及居家照護模式的轉變，都進一步推動了市場需求。

根據世界衛生組織（WHO，2022）的數據，針刺傷是醫護人員最嚴重的職業危害之一，每年在3,500萬醫護人員中發生超過200萬起職業暴露事件。針刺傷使醫護人員面臨感染愛滋病毒、B型肝炎和C型肝炎等嚴重血液傳染感染疾病的風險，因此成為針頭安全裝置市場的主要促進因素。醫院、診所和檢查室中此類事故的頻繁發生，使得人們迫切需要能夠預防意外針刺傷並提高工作場所安全性的裝置。

此外，根據國際糖尿病聯盟（2025年）的預測，全球約有5.89億成年人（20-79歲）將患有糖尿病。糖尿病患者通常每天需要多次注射，導致臨床和家庭環境中針頭使用量增加。這種使用頻率的增加提高了患者、看護者和醫護人員意外針刺傷的風險，凸顯了設計安全注射裝置的必要性，並推動了針頭安全裝置市場的成長。

此外，免疫接種和疫苗接種計劃的擴展，透過增加注射器和針頭的使用量，提高了針刺傷的風險，從而推動了針頭安全裝置市場的成長。根據世界衛生組織（WHO，2025）提供的數據，全球女孩首次接種人類乳突病毒（人類乳突病毒(HPV)疫苗）疫苗的比例從2023年的27%上升到2024年的31%。隨著各國將免疫接種目標從嬰幼兒擴展到青少年和青年，HPV疫苗接種率的提高持續推動了對安全注射器和針頭安全裝置的需求，顯著促進了整個針頭安全裝置市場的發展。 HPV人類乳突病毒(HPV)疫苗通常需要兩到三次肌肉注射，目前已被納入低收入、中等收入和高所得國家的國家免疫規劃，用於預防子宮頸癌和其他HPV相關癌症。隨著越來越多的政府和國際衛生合作夥伴在學校和社區擴大疫苗宣傳活動，疫苗劑量增加，也相應地增加了對安全注射器和針頭安全裝置的需求。

然而，產品研發活動的增加進一步推動了整個呼吸照護設備市場的發展。例如，2026年1月，泰爾茂株式會社的完全子公司泰爾茂醫療株式會社宣佈在美國推出SurTract™安全注射器，該產品採用了由Roncadelle Operations Srl開發的Safe®被動安全技術。

因此，由於上述因素，預計從 2023 年到 2034 年的預測期內，呼吸照護設備市場整體將擴大。

然而，一次性注射器和針頭的廣泛使用產生了大量的醫療銳器廢棄物，需要安全處置，因此針頭安全裝置市場面臨著與環境問題和廢棄物管理相關的挑戰。不當的處理和處置會導致環境污染和健康風險。此外，由於製造缺陷、安全問題或不合規等原因導致的產品召回增加，會擾亂供應鏈，削弱市場信心，並阻礙產品的普及。這些因素共同限制了市場成長，並凸顯了改善廢棄物管理和品管措施的必要性。

針頭安全裝置市場區隔分析

按產品類型（針頭安全裝置{安全皮下注射針、安全注射筆針、安全採血針等}、安全靜脈導管、安全注射器）、安全機制（主動安全裝置和被動安全裝置）、最終用戶（醫院和診所、門診手術中心、居家醫療機構等）和地區（北美、歐洲、亞太地區和世界其他地區市場分類的針頭安全裝置市場。

針頭安全裝置市場區域分析

北美針頭安全裝置市場趨勢

預計到 2025 年，北美將佔據所有地區針頭安全裝置市場最大的佔有率，達到 38%。這一主導地位歸功於大規模疫苗接種計劃以及慢性病注射療法廣泛應用的推動。

根據美國疾病管制與預防中心（CDC，2024）估計，美國醫護人員每年約有38.5萬起針刺傷和其他銳器傷。醫護人員意外針刺傷的增加加劇了人們對愛滋病毒、B型肝炎和C型肝炎等血液傳染感染疾病的擔憂。因此，醫院和診所正在逐步採用安全設計的器械，例如可伸縮注射器和帶防護罩的針頭，以符合職業安全標準並保護醫務人員。這種對職場安全日益成長的關注，正顯著推動針頭安全器械市場的擴張。

此外，根據國際癌症研究機構（IARC）的預測，美國2025年新增癌症病例將達254萬例，到2045年將進一步增加至338萬例。癌症發生率的上升顯著推動了針頭安全裝置市場的成長，因為患者需要頻繁注射和進行與血液相關的操作。化療、免疫療法、標靶治療、輸血和常規血液檢查等治療都需要反覆使用針頭，因此對更安全的注射技術的需求日益成長。這種對兼顧防護功能和安全性的醫療設備日益成長的需求，正在加速針頭安全裝置市場的擴張。然而，產品研發活動的增加也進一步推動了整個針頭安全裝置市場的發展。例如，2026年1月，泰爾茂株式會社的完全子公司泰爾茂醫療株式會社宣佈在美國推出SurTract™安全注射器，該產品採用了由Roncadelle Operations Srl公司開發的Safe®被動安全技術。

因此，預計以上所有因素將在預測期內推動北美針頭安全裝置市場的發展。

歐洲針頭安全裝置市場趨勢

歐洲針頭安全裝置市場的主要促進因素是外科手術數量的增加、疫苗接種工作的廣泛開展以及需要定期注射治療的慢性疾病盛行率的上升。

根據國際糖尿病聯盟（2025）的數據，2024年歐洲20至79歲糖尿病患者人數估計為6,560萬，預計2050年將增加至7,240萬。相當一部分糖尿病患者需要每日注射胰島素、定期監測血糖值，在某些情況下還需要注射GLP-1受體促效劑。頻繁且長期使用針頭會增加醫護人員和病患發生意外針刺傷的風險，尤其是在居家照護環境中。因此，人們對更安全的注射技術的需求日益成長，這也推動了針頭安全裝置市場的擴張。

然而，不斷增加的產品研發活動正在進一步推動整個針頭安全裝置市場的發展。例如，2024年1月，Medmix Drug Delivery（Haselmeier）在巴黎舉行的歐洲醫藥包裝展（Pharmapack Europe）上發布了其被動式針頭安全裝置SicuroJect™，進一步拓展了產品系列。

因此，預計以上所有因素將在預測期內推動歐洲針頭安全裝置市場的發展。

亞太地區針頭安全裝置市場趨勢

在亞太地區，外科手術數量的增加、大規模疫苗接種計劃以及需要定期注射的慢性疾病的日益普遍，推動了針頭安全裝置市場的發展。

根據國際癌症研究機構（IARC）的預測，日本癌症患者人數預計將在2025年達到104萬，到2045年將增加至約106萬人。由於腫瘤治療高度依賴注射和診斷性針刺操作，癌症發生率的上升是針頭安全裝置市場的主要驅動力。接受癌症治療的患者通常需要接受注射、輸血以及頻繁的血液檢查，用於化療、免疫療法、標靶治療和支持性治療。這些治療中持續且頻繁的針頭使用增加了醫護人員意外針刺傷的風險，因此凸顯了先進安全裝置的必要性。

此外，根據國際糖尿病聯盟（2025）的數據，預計到2024年，日本20至79歲糖尿病患者人數將達到1080萬，並預計到2050年將減少至940萬。許多醣尿病患者依賴每日胰島素注射、定期血糖值監測，在某些情況下還需要使用非胰島素注射藥物。頻繁且長期使用針頭會增加醫護人員和患者發生意外針刺傷的風險，尤其是在居家照護和自行注射的情況下。因此，人們對更安全的注射方法的需求日益成長，這也推動了針頭安全裝置市場的成長。

因此，由於上述因素，預計全部區域的針頭安全裝置市場將擴大。

針頭安全裝置市場的主要參與者有哪些公司？

以下是針頭安全裝置市場的主要參與者。這些公司通常佔據最大的市場佔有率，並引領行業趨勢。

  • BD
  • Terumo Corporation
  • Nipro
  • ICU Medical
  • B.Braun
  • Retractable Technologies, Inc
  • AdvaCare Pharma
  • Medtronic
  • Hindustan Syringes &Medical Devices Ltd
  • Cardinal Health
  • Vygon SA
  • Gerresheimer AG
  • West Pharmaceutical Services, Inc.
  • UltiMed, Inc.
  • Argon Medical Devices, Inc
  • NOVO NORDISK A/S
  • Kindly（KDL）Meditech
  • Weigao Group
  • Jiangsu Jichun Medical Devices Co., Ltd.
  • Sarstedt AG &Co. KG
  • 其他

競爭格局對針頭安全裝置市場有何影響？

針頭安全裝置市場的競爭格局日益複雜，主要參與者之間不斷進行創新、建立策略聯盟並實現產品多元化。各公司致力於開發高度安全的裝置，包括被動式和自回縮式針頭、安全注射器和無針注射系統，以滿足日益嚴格的監管要求和醫療機構的需求。策略聯盟、併購等方式使製造商能夠拓展產品系列、強化全球分銷網路並加速市場滲透，尤其是在新興市場。

除了技術進步之外，對人體工學設計、易用性和成本效益的重視也加劇了競爭，因為醫療專業人員優先考慮那些既能提高安全性又不影響操作效率的設備。領先企業也加大研發投入，推出環境永續產品，例如可回收或環保注射器，以滿足日益成長的綠色醫療解決方案需求。此外，區域部署策略、在地化生產以及與監管機構積極合作以加速核准和部署，都在重塑競爭格局。

整體而言，針頭安全裝置市場競爭非常激烈，創新、合規性和策略性成長舉措是企業脫穎而出、獲得市場佔有率並滿足全球醫療保健提供者不斷變化的需求的關鍵促進因素。

針頭安全裝置市場近期發展趨勢

  • 2026 年 1 月，泰爾茂株式會社的完全子公司Terumo Medical Corp.株式會社宣佈在美國推出 SurTract™ 安全注射器，該注射器採用了 Roncadelle Operations Srl 開發的 Safe® 被動安全技術。

針頭安全裝置市場的市場區隔

  • 按產品類型分類的針頭安全裝置市場規模
  • 針頭安全裝置
  • 安全皮下注射針
  • 安全筆針
  • 安全採血針
  • 其他
  • 安全靜脈導管
  • 安全注射器
  • 針頭安全裝置的安全機制暴露
  • 主動安全裝置
  • 被動式安全裝置
  • 最終使用者接觸針頭安全裝置
  • 醫院和診所
  • 門診手術中心
  • 居家醫療
  • 其他
  • 針頭安全裝置的區域市場趨勢
  • 北美針頭安全裝置市場
  • 美國針頭安全裝置市場
  • 加拿大針頭安全裝置市場
  • 墨西哥針頭安全裝置市場
  • 歐洲針頭安全裝置市場
  • 英國針頭安全裝置市場
  • 德國針頭安全裝置市場
  • 法國針頭安全裝置市場
  • 義大利針頭安全裝置市場
  • 西班牙針頭安全裝置市場
  • 其他歐洲國家的針頭安全裝置市場
  • 亞太地區針頭安全裝置市場
  • 中國針頭安全裝置市場
  • 日本針頭安全裝置市場
  • 印度針頭安全裝置市場
  • 澳洲針頭安全裝置市場
  • 韓國針頭安全裝置市場
  • 亞太地區其他針頭安全裝置市場
  • 其他地區的針頭安全裝置市場
  • 南美洲針頭安全裝置市場
  • 中東針頭安全裝置市場
  • 非洲針頭安全裝置市場

影響分析

人工智慧驅動的創新與應用：

人工智慧 (AI) 正透過增強設備功能、提高安全標準合規性以及最佳化醫療工作流程，日益變革針頭安全裝置市場。 AI 驅動的創新實現了諸多功能，例如即時監測針頭使用情況、自動驗證安全機制啟動情況以及利用預測分析識別高風險操作和使用者錯誤。這些應用不僅降低了針刺傷的發生率，還為醫院管理者提供了寶貴的數據，用於追蹤設備使用情況、確保合規性以及為醫護人員實施針對性培訓計劃。此外，AI 的整合正在加速更智慧安全裝置的開發，例如連網注射器和導管。這些裝置可以在針頭未妥善保護或未回縮時發出警報。透過將先進的安全機制與 AI 洞察相結合，這些創新正在提高營運效率、增強職業安全，並促進針頭安全裝置在醫院、診所和診斷檢查室的廣泛應用，從而推動該領域的市場成長和技術進步。

美國關稅對針頭安全裝置市場的影響分析：

美國加徵關稅對針頭安全裝置市場產生了重大影響，波及定價、供應鏈和市場動態。醫療設備和原料進口關稅的提高推高了依賴海外零件的製造商的生產成本，最終導致包括醫院、診所和診斷檢查室在內的終端用戶面臨更高的價格。這些關稅也迫使企業重新評估其供應鏈，許多企業透過分散本地原料採購和製造地來緩解成本壓力。儘管面臨這些挑戰，但由於監管合規、醫療保健成本上漲以及預防工傷事故的需要，對安全型針頭的需求不斷成長，推動了市場的持續成長。 BD（貝克頓·迪金森公司）、泰爾茂株式會社和ICU Medical等公司正在採取策略措施，包括擴大區域生產和調整價格，以抵消關稅帶來的影響，並確保針頭安全裝置在美國市場的持續供應和分銷。

這項分析能為客戶帶來哪些好處？

  • 成本管理：透過了解關稅趨勢，客戶可以預測成本上漲，並據此調整定價策略，以確保盈利。
  • 供應鏈最佳化：透過尋找替代供應商並使其供應鏈多元化，客戶可以減少對高關稅地區的依賴，並增強業務永續營運。
  • 監管合規：專家指導幫助客戶應對不斷變化的法規環境，從而保持合規並避免潛在的法律挑戰。
  • 策略規劃：深入了解關稅的影響，使客戶能夠就製造地、夥伴關係和打入市場策略做出明智的決策。

針頭安全裝置市場報告要點

  • 針頭安全裝置市場目前市場規模分析（2025 年）及 8 年市場預測（2026 年至 2034 年）
  • 過去三年發生的主要產品和技術開發、併購、合作和合資企業
  • 主導針頭安全裝置市場的主要公司
  • 針頭安全裝置市場的其他競爭者也面臨各種機會。
  • 哪些細分市場在 2025 年表現最佳？這些細分市場在 2034 年的表現又會如何？
  • 目前哪些地區、國家在針頭安全裝置市場表現最佳？
  • 企業應專注於哪些地區或國家，以尋求針頭安全裝置市場的未來成長機會？

關於針頭安全裝置市場的常見問題

1. 針頭安全裝置市場的成長率是多少？

  • 預計從 2026 年到 2034 年的預測期內，針頭安全裝置市場將以 5.39% 的年複合成長率成長。

2. 什麼是針頭安全裝置市場？

  • 全球針頭安全裝置市場預計將從 2025 年的 228415 億美元成長到 2034 年的 363749 億美元，表明市場將保持強勁且持續的成長。

3. 哪個地區在針頭安全裝置市場中佔據最大的市場佔有率？

  • 北美地區預計將成為全球針頭安全裝置市場的主要驅動力，這得益於該地區對針刺傷的高度重視、嚴格的安全法規以及安全型注射器的廣泛應用。慢性病盛行率的上升、疫苗接種計劃的擴大以及家庭醫療保健需求的增加也推動了市場成長。此外，自動針頭保護裝置和可伸縮技術的進步提高了安全性和易用性，進一步促進了該地區的穩定成長。

4. 針頭安全裝置市場的成長要素為何？

  • 針頭安全裝置市場成長的主要促進因素是意外針刺傷事件的增加以及醫護人員對血液傳染感染疾病日益成長的擔憂。此外，慢性病患者需要反覆注射，加上免疫接種工作的擴展和醫療成本的上升，也進一步推動了市場擴張。同時，居家醫療和注射療法的自我管理模式的普及，也使得對更安全裝置的需求更加迫切。被動式和自動化儲存技術的不斷創新，提高了安全性、易用性和合規性，從而推動了整體市場成長。

5. 針頭安全裝置市場的主要企業有哪些？

  • 針頭安全裝置市場的主要參與企業包括 BD、Terumo Corporation、Nipro、ICU Medical、B.Braun、Retractable Technologies、AdvaCare Pharma、Medtronic、Hindustan Syringes & Medical Devices Ltd.、Cardinal Health、Vygon SA、Gerresheimer AG、SWestuity, Inc. (KDL) Meditech、Weigao Group、江蘇吉春醫療器材有限公司和 Sarstedt AG & CO. KG。

目錄

第1章：針頭安全裝置市場報告概述

  • 調查範圍
  • 市場區隔
  • 市場預期

第2章：針頭安全裝置市場執行摘要

  • 市場概覽

第3章：針頭安全裝置市場的關鍵因素

  • 針頭安全裝置的市場促進因素
  • 針頭安全裝置的市場限制與挑戰
  • 針頭安全裝置市場的機遇

第4章：影響分析

  • 美國關稅影響分析

第5章：監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章：針頭安全裝置市場的波特五力分析

第7章：針頭安全裝置市場評估

  • 依產品類型
    • 針頭安全裝置
    • 安全注射器
    • 安全靜脈導管
  • 透過安全機制
    • 主動安全裝置
    • 被動式安全裝置
  • 最終用戶
    • 醫院和診所
    • 門診手術中心
    • 居家照護環境
    • 其他
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 競爭情勢

第9章：針頭安全裝置市場中的公司與產品概況

  • BD
  • Terumo Corporation
  • Nipro
  • ICU Medical
  • B.Braun SE
  • Retractable Technologies, Inc.
  • AdvaCare Pharma
  • Medtronic
  • Hindustan Syringes & Medical Devices Ltd.
  • Cardinal Health
  • Vygon SA
  • Gerresheimer AG
  • West Pharmaceutical Services, Inc.
  • UltiMed, Inc.
  • Argon Medical Devices, Inc.
  • Novo Nordisk A/S
  • Kindly (KDL) Meditech
  • Weigao Group
  • Jiangsu Jichun Medical Devices Co., Ltd.
  • Sarstedt AG& Co. KG

第10章：KOL的視角

第11章 專案方法

第12章：關於 DelveInsight

第13章 免責聲明與聯絡方式

Product Code: DIMDCL0894

Needle Safety Devices Market Summary

  • The global needle safety devices market is expected to increase from USD 2,284.15 million in 2025 to USD 3,637.49 million by 2034, reflecting strong and sustained growth.
  • The global needle safety devices market is growing at a CAGR of 5.39% during the forecast period from 2026 to 2034.
  • The growth of the needle safety devices market is largely attributed to the increasing number of accidental needlestick injuries and the heightened concern over the transmission of blood-borne infections among healthcare professionals. The rising burden of chronic conditions that require repeated injections, along with expanding vaccination initiatives and higher healthcare spending, is further contributing to market expansion. Moreover, the shift toward home healthcare and self-administration of injectable therapies is creating additional demand for safer devices. Continuous innovations in passive and auto-retractable technologies are also improving safety, ease of use, and regulatory compliance, thereby driving overall market growth.
  • The leading companies operating in the needle safety devices market include BD, Terumo Corporation, Nipro, ICU Medical, B.Braun, Retractable Technologies, AdvaCare Pharma, Medtronic, Hindustan Syringes & Medical Devices Ltd., Cardinal Health, Vygon SA, Gerresheimer AG, West Pharmaceutical Services, Inc., UltiMed, Inc., Argon Medical Devices, Inc., Novo Nordisk A/S, Kindly (KDL) Meditech, Weigao Group, Jiangsu Jichun Medical Devices Co., Ltd., Sarstedt AG & CO. KG and others.
  • North America is expected to remain a leading region in the global needle safety devices market due to strong awareness about needlestick injuries and the importance of reducing infection risks in healthcare settings. Strict safety regulations and workplace protection policies support the widespread use of safety-engineered injection devices. The rising number of patients with chronic diseases, increasing vaccination programs, and growing use of home-based treatments are also driving demand. Additionally, continuous improvements in automatic shielding and needle-retraction technologies are enhancing safety and supporting steady market growth in the region.
  • In the product type segment of the needle safety devices market, under the safety needles segment, safety hypodermic needles category is estimated to account for the largest market share in 2025.

Factors Contributing to the Growth of the Needle Safety Devices Market

  • Rising incidence of needlestick injuries: The increasing occurrence of needlestick injuries is significantly driving the growth of the needle safety devices market, as accidental sharps injuries continue to pose serious occupational hazards in healthcare settings. Needlestick injuries expose healthcare workers to bloodborne pathogens such as HIV, hepatitis B, and hepatitis C, leading to serious health risks, psychological stress, and increased healthcare costs. The growing volume of injections administered for vaccinations, chronic disease management, and emergency care has increased routine exposure to needles among healthcare professionals. As a result, healthcare institutions are prioritizing the adoption of safety-engineered devices with built-in protective features to reduce accidental exposure. This heightened focus on prevention and risk management is creating strong and sustained demand for needle safety technologies worldwide.
  • Increasing chronic conditions such as diabetes, cancer, autoimmune disorders requiring frequent injections: The increasing prevalence of chronic conditions such as diabetes, cancer, and autoimmune disorders is significantly driving the growth of the needle safety devices market, as these diseases often require long-term and repeated injectable treatments. Patients undergoing insulin therapy, chemotherapy, biologic drug administration, and hormone treatments depend on frequent injections in hospitals, specialty clinics, and home-care settings. The growing adoption of self-administration therapies, particularly for diabetes and autoimmune diseases, has increased the need for safer and more user-friendly injection devices to minimize accidental injuries. Additionally, the expanding geriatric population, which is more prone to chronic illnesses, is further contributing to higher injection volumes worldwide. This sustained rise in injectable treatments is creating strong demand for advanced safety syringes and protective needle technologies, thereby supporting overall market expansion.
  • Increase in vaccination & immunization programs: The increase in vaccination and immunization programs is a significant driver of the needle safety devices market, as large-scale vaccine administration requires safe and reliable injection practices. Government-led public health initiatives, routine childhood immunization schedules, and mass vaccination campaigns for infectious diseases have substantially increased the volume of injections administered worldwide. This high usage creates a strong need for safety syringes and auto-disable devices to prevent needle reuse and cross-contamination. Additionally, global efforts to improve immunization coverage in developing regions and preparedness for emerging disease outbreaks are further boosting procurement of safety-engineered injection products. As a result, the expanding scope of vaccination programs continues to generate consistent demand for needle safety devices across healthcare systems.
  • Growth in self-administration & home healthcare: The growth in self-administration and home healthcare is significantly driving the needle safety devices market, as an increasing number of patients are managing long-term conditions outside traditional hospital settings. Treatments for diabetes, autoimmune disorders, hormonal deficiencies, and other chronic illnesses often require regular injectable medications, prompting patients to use insulin pens, prefilled syringes, and biologic injectables at home. This shift toward convenient and cost-effective care has increased the demand for easy-to-use, reliable, and protective injection devices that minimize accidental injuries. Additionally, the rising elderly population, preference for outpatient care, and advancements in drug delivery systems are further accelerating the adoption of safety-integrated needles and pen devices in home environments, thereby contributing to sustained market expansion.
  • Increase in product development activites: The increase in product development activities is significantly driving the growth of the needle safety devices market, as manufacturers focus on introducing more efficient, user-friendly, and compliant safety solutions. Companies are investing in research and development to design innovative devices with improved ergonomic features, enhanced shielding mechanisms, and integrated safety technologies that reduce activation errors. The shift toward passive safety systems, compact designs for home healthcare use, and compatibility with prefilled syringes and biologics is further accelerating innovation. In addition, collaborations, strategic partnerships, and regulatory approvals for next-generation products are expanding product portfolios and strengthening competitive positioning. These continuous advancements are improving clinical efficiency and encouraging faster adoption across healthcare settings, thereby supporting overall market expansion.

Needle Safety Devices Market Report Segmentation

This needle safety devices market report offers a comprehensive overview of the global needle safety devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Safety Needles {Safety Hypodermic Needles, Safety Pen Needles, Safety Blood Collection Needles, and Others} Safety IV Catheters, and Safety Syringes), Safety Mechanism (Active Safety Devices and Passive Safety Devices), End-Users (Hospitals & Clinics, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing needle safety devices market.

Needle safety devices are medical instruments designed with built-in protective mechanisms that reduce the risk of accidental needlestick injuries during and after the use of needles. These devices incorporate safety features such as retractable needles, sliding shields, protective sheaths, or automatic locking systems that cover or withdraw the needle immediately after use.

The global needle safety devices market is being propelled by several interrelated factors that are collectively strengthening product adoption across healthcare systems worldwide. One of the primary drivers is the rising incidence of needlestick injuries among healthcare professionals. Hospitals and clinical laboratories are increasingly prioritizing occupational safety to reduce the risk of transmission of bloodborne infections such as HIV and hepatitis. Moreover, another growth factor is the expanding volume of surgical procedures, vaccinations, and chronic disease treatments. The increasing prevalence of diabetes, cancer, and cardiovascular disorders has led to a higher frequency of injections, IV therapies, and blood sampling procedures, thereby driving the need for safer needle technologies.

Technological advancements are further contributing to market expansion. Manufacturers are introducing passive safety mechanisms, auto-retractable syringes, and user-friendly designs that enhance efficiency while minimizing manual handling. These innovations are improving product reliability and encouraging broader adoption across healthcare facilities.

Collectively, these factors are driving sustained growth in the global needle safety devices market by aligning regulatory compliance, technological innovation, and occupational safety priorities with increasing healthcare demand.

What are the latest needle safety devices market dynamics and trends?

The needle safety devices market has grown due to the rising incidence of needlestick injuries and concerns over blood-borne infections among healthcare workers. Increasing chronic disease prevalence, expanding vaccination programs, higher healthcare spending, and the shift toward home-based therapies have further driven demand.

According to the World Health Organization (2022), needlestick injuries were among the most serious occupational hazards for healthcare workers (HCWs), with over 2 million occupational exposures occurring annually among 35 million HCWs. Needlestick injuries are a key driver of the needle safety devices market, as they expose healthcare workers to serious blood-borne infections such as HIV, Hepatitis B, and Hepatitis C. The frequent occurrence of these injuries in hospitals, clinics, and laboratories has created a pressing demand for devices designed to prevent accidental needle pricks and enhance occupational safety.

Moreover, according to the International Diabetes Federation (2025), approximately 589 million adults (aged 20-79 years) were living with diabetes globally. Individuals with diabetes frequently require multiple daily injections, increasing needle usage in both clinical and home settings. This higher exposure raises the risk of accidental needlestick injuries for patients, caregivers, and healthcare professionals, underscoring the essential need for safety-engineered injection devices and driving the growth of the needle safety devices market.

Furthermore, the expansion of vaccination and immunization programs is driving growth in the needle safety devices market by increasing syringe and needle usage, which raises the risk of needlestick injuries. According to the data provided by the World Health Organization (2025), the global coverage for the first dose of HPV vaccine in girls grew from 27% in 2023 to 31% in 2024. The increasing uptake of human papillomavirus (HPV) vaccination is significantly boosting the overall market for needle safety devices by driving sustained demand for safe injectable delivery tools as countries expand immunization beyond infancy to include adolescents and young adults. HPV vaccines administered typically in two or three intramuscular injections are now being integrated into national immunization schedules across low-, middle-, and high-income countries to prevent cervical and other HPV-related cancers. As more governments and global health partners scale up school-based and community vaccination campaigns, the volume of administered injections rises, creating a proportional need for safety syringes and needles.

However, the increase in product development activities is further boosting the overall market of respiratory care devices. For instance, in January 2026, Terumo Medical Corporation, a wholly owned subsidiary of Terumo Corporation, announced the U.S. launch of its SurTract(TM) Safety Syringe, featuring SafeR(R) passive safety technology developed by Roncadelle Operations S.r.l.

Thus, the factors mentioned above are expected to boost the overall market of respiratory care devices during the forecast period from 2023 to 2034.

However, the needle safety devices market faces challenges related to environmental and waste management concerns, as the widespread use of single-use syringes and needles generates large volumes of medical sharps waste that require safe disposal. Improper handling and disposal can lead to environmental pollution and pose health risks. Additionally, increasing product recalls due to manufacturing defects, safety issues, or regulatory non-compliance can disrupt supply chains, affect market confidence, and hinder adoption. Together, these factors act as restraints on market growth and emphasize the need for improved waste management and quality control measures.

Needle Safety Devices Market Segment Analysis

Needle Safety Devices Market by Product Type (Safety Needles {Safety Hypodermic Needles, Safety Pen Needles, Safety Blood Collection Needles, and Others} Safety IV Catheters, and Safety Syringes), Safety Mechanism (Active Safety Devices and Passive Safety Devices), End-Users (Hospitals & Clinics, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Needle Safety Devices Market Regional Analysis

North America Needle Safety Devices Market Trends

North America is expected to account for the highest proportion of 38% of the needle safety devices market in 2025, out of all regions. This dominance is driven by increasing number of surgical procedures, large-scale vaccination programs, and widespread treatment of chronic diseases requiring injectable therapies significantly boost the demand for safety syringes and retractable needle devices in the region.

According to the Centers for Disease Control and Prevention (2024), an estimated 385,000 needlestick and other sharps-related injuries were sustained annually by hospital-based healthcare personnel in the United States. The increasing occurrence of accidental needlestick injuries among healthcare professionals has intensified concerns about the transmission of blood-borne infections such as HIV, hepatitis B, and hepatitis C. Consequently, hospitals and clinics are progressively adopting safety-engineered devices, including retractable syringes and shielded needles, to comply with occupational safety standards and safeguard medical staff. This growing emphasis on workplace protection is significantly driving the expansion of the needle safety devices market.

Moreover, according to the International Agency for Research on Cancer, the estimated number of new cancer cases in the United States was projected to reach 2.54 million in 2025 and was expected to increase further to 3.38 million by 2045. The increasing prevalence of cancer is substantially driving the growth of the needle safety devices market, as patients require frequent injectable therapies and blood-related procedures. Treatments such as chemotherapy, immunotherapy, targeted therapy, blood transfusions, and routine diagnostic blood tests involve repeated needle use, heightening the need for safer injection practices. This growing demand for protective and safety-engineered devices is consequently accelerating the expansion of the needle safety devices market. However, the increase in product development activities is further boosting the overall market of needle safety devices. For instance, in January 2026, Terumo Medical Corporation, a wholly owned subsidiary of Terumo Corporation, announced the U.S. launch of its SurTract(TM) Safety Syringe, featuring SafeR(R) passive safety technology developed by Roncadelle Operations S.r.l.

Thus, all the above-mentioned factors are anticipated to propel the market for needle safety devices in North America during the forecast period.

Europe Needle Safety Devices Market Trends

In Europe, the needle safety devices market is primarily driven by the rising volume of surgical procedures, extensive immunization initiatives, and the growing prevalence of chronic diseases that require regular injectable treatments.

According to the International Diabetes Federation (2025), the number of adults aged 20-79 years living with diabetes in Europe was estimated at 65.6 million in 2024 and was projected to rise to 72.4 million by 2050. A significant proportion of individuals with diabetes require daily insulin injections, routine blood glucose monitoring, and, in some cases, injectable GLP-1 receptor agonists. The frequent and long-term use of needles heightens the risk of accidental needlestick injuries for both healthcare providers and patients, especially in home-care environments. This growing need for safer injection practices is consequently driving the expansion of the needle safety devices market.

However, the increase in product development activities is further boosting the overall market of needle safety devices. For instance, In January 2024, Medmix Drug Delivery (Haselmeier) launched its passive needle safety device, SicuroJect(TM), at Pharmapack Europe held in Paris, further expanding its product portfolio in drug delivery solutions.

Hence, all the factors mentioned above are expected to drive the market for needle safety devices in Europe during the forecast period.

Asia-Pacific Needle Safety Devices Market Trends

In the Asia Pacific region, the needle safety devices market is driven by the growing number of surgical procedures, large-scale vaccination programs, and the increasing prevalence of chronic diseases requiring regular injections.

According to the International Agency for Research on Cancer, the estimated number of cancer cases in Japan was projected to reach 1.04 million in 2025 and is expected to increase to approximately 1.06 million by 2045. The increasing prevalence of cancer is playing a major role in driving the needle safety devices market, as oncology care relies heavily on injectable therapies and diagnostic needle-based procedures. Patients undergoing cancer treatment often receive chemotherapy, immunotherapy, targeted therapies, supportive injections, blood transfusions, and frequent blood tests. The continuous and intensive use of needles in these treatments elevates the risk of accidental needlestick injuries for healthcare workers, thereby reinforcing the need for advanced safety devices.

Moreover, according to the International Diabetes Federation (2025), the number of adults aged 20-79 years living with diabetes in Japan was estimated at 10.8 million in 2024 and is projected to decline to 9.4 million by 2050. A significant number of individuals with diabetes depend on daily insulin injections, routine blood glucose testing, and, in some cases, injectable non-insulin medications. The frequent and long-term use of needles elevates the likelihood of accidental needlestick injuries for both healthcare providers and patients, especially in home-care and self-administration settings. This increasing need for safer injection practices is consequently driving the growth of the needle safety devices market.

Thus, the factors mentioned above are expected to boost the market of needle safety devices across the Asia-Pacific region.

Who are the major players in the needle safety devices market?

The following are the leading companies in the needle safety devices market. These companies collectively hold the largest market share and dictate industry trends.

  • BD
  • Terumo Corporation
  • Nipro
  • ICU Medical
  • B.Braun
  • Retractable Technologies, Inc
  • AdvaCare Pharma
  • Medtronic
  • Hindustan Syringes & Medical Devices Ltd
  • Cardinal Health
  • Vygon SA
  • Gerresheimer AG
  • West Pharmaceutical Services, Inc.
  • UltiMed, Inc.
  • Argon Medical Devices, Inc
  • NOVO NORDISK A/S
  • Kindly (KDL) Meditech
  • Weigao Group
  • Jiangsu Jichun Medical Devices Co., Ltd.
  • Sarstedt AG & Co. KG
  • Others

How is the competitive landscape shaping the needle safety devices market?

The competitive landscape of the needle safety devices market is increasingly dynamic, characterized by intense innovation, strategic partnerships, and product diversification among key players. Companies are focusing on developing advanced safety-engineered devices, including passive and auto-retractable needles, safety syringes, and needle-free injection systems, to meet growing regulatory requirements and healthcare facility demands. Strategic collaborations, mergers, and acquisitions are enabling manufacturers to expand their product portfolios, strengthen global distribution networks, and enhance market penetration, particularly in emerging regions.

In addition to technological advancements, competition is driven by the emphasis on ergonomic designs, ease of use, and cost-effectiveness, as healthcare providers prioritize devices that enhance safety without compromising workflow efficiency. Leading players are also investing in research and development to introduce environmentally sustainable products, such as recyclable or eco-friendly syringes, catering to increasing demand for green healthcare solutions. The competitive environment is further shaped by regional expansion strategies, localized manufacturing, and proactive engagement with regulatory bodies to accelerate approvals and adoption.

Overall, the needle safety devices market is witnessing robust competition, where innovation, compliance, and strategic growth initiatives are the primary factors enabling companies to differentiate themselves, capture market share, and meet the evolving needs of healthcare providers globally.

Recent Developmental Activities in the Needle Safety Devices Market

  • In January 2026, Terumo Medical Corporation, a wholly owned subsidiary of Terumo Corporation, announced the U.S. launch of its SurTract(TM) Safety Syringe, featuring SafeR(R) passive safety technology developed by Roncadelle Operations S.r.l.

Needle Safety Devices Market Segmentation

  • Needle Safety Devices by Product Type Exposure
  • Safety Needles
  • Safety Hypodermic Needles
  • Safety Pen Needles
  • Safety Blood Collection Needles
  • Others
  • Safety IV Catheters
  • Safety Syringes
  • Needle Safety Devices Safety Mechanism Exposure
  • Active Safety Devices
  • Passive Safety Devices
  • Needle Safety Devices End-Users Exposure
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Others
  • Needle Safety Devices Geography Exposure
  • North America Needle Safety Devices Market
  • United States Needle Safety Devices Market
  • Canada Needle Safety Devices Market
  • Mexico Needle Safety Devices Market
  • Europe Needle Safety Devices Market
  • United Kingdom Needle Safety Devices Market
  • Germany Needle Safety Devices Market
  • France Needle Safety Devices Market
  • Italy Needle Safety Devices Market
  • Spain Needle Safety Devices Market
  • Rest of Europe Needle Safety Devices Market
  • Asia-Pacific Needle Safety Devices Market
  • China Needle Safety Devices Market
  • Japan Needle Safety Devices Market
  • India Needle Safety Devices Market
  • Australia Needle Safety Devices Market
  • South Korea Needle Safety Devices Market
  • Rest of Asia-Pacific Needle Safety Devices Market
  • Rest of the World Needle Safety Devices Market
  • South America Needle Safety Devices Market
  • Middle East Needle Safety Devices Market
  • Africa Needle Safety Devices Market

Impact Analysis

AI-Powered Innovations and Applications:

Artificial intelligence (AI) is increasingly transforming the needle safety devices market by enhancing device functionality, improving safety compliance, and optimizing healthcare workflows. AI-powered innovations enable features such as real-time monitoring of needle usage, automatic verification of safety mechanism activation, and predictive analytics to identify high-risk procedures or user errors. These applications not only reduce the incidence of needlestick injuries but also provide valuable data for hospital administrators to track device utilization, ensure regulatory compliance, and implement targeted training programs for healthcare professionals. Additionally, AI integration facilitates the development of smarter safety devices, such as connected syringes and catheters, which can alert users if the needle is not properly shielded or retracted. By combining advanced safety mechanisms with AI-driven insights, these innovations are improving operational efficiency, enhancing occupational safety, and driving greater adoption of needle safety devices across hospitals, clinics, and diagnostic laboratories, thereby strengthening market growth and technological advancement in the sector.

U.S. Tariff Impact Analysis on Needle Safety Devices Market:

The imposition of tariffs in the United States has had a notable impact on the needle safety devices market, influencing pricing, supply chains, and overall market dynamics. Increased import duties on medical devices and raw materials have raised the cost of production for manufacturers relying on overseas components, leading to higher prices for end-users, including hospitals, clinics, and diagnostic laboratories. These tariffs have also prompted companies to reassess their supply chains, with many seeking to source materials locally or diversify manufacturing locations to mitigate cost pressures. Despite these challenges, the growing demand for safety-engineered needles, driven by regulatory compliance, rising healthcare expenditure, and the need to prevent occupational injuries, has helped sustain market growth. Companies such as BD (Becton, Dickinson and Company), Terumo Corporation, and ICU Medical have adopted strategic measures, including regional production expansions and pricing adjustments, to offset tariff-related impacts, ensuring continued availability and adoption of needle safety devices in the U.S. market.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the needle safety devices market report study

  • Market size analysis for the current needle safety devices market size (2025), and market forecast for 8 years (2026 to 2034)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the needle safety devices market.
  • Various opportunities available for the other competitors in the needle safety devices market space.
  • What are the top-performing segments in 2025? How these segments will perform in 2034?
  • Which are the top-performing regions and countries in the current needle safety devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the needle safety devices market growth in the future?

Frequently Asked Questions for the Needle Safety Devices Market

1. What is the growth rate of the needle safety devices market?

  • The needle safety devices market is estimated to grow at a CAGR of 5.39% during the forecast period from 2026 to 2034.

2. What is the market for needle safety devices?

  • The global needle safety devices market is expected to increase from USD 2,284.15 million in 2025 to USD 3,637.49 million by 2034, reflecting strong and sustained growth.

3. Which region has the highest share in the needle safety devices market?

  • North America is expected to lead the global needle safety devices market due to strong awareness of needlestick injuries, strict safety regulations, and widespread adoption of safety-engineered injection devices. Market growth is supported by the rising prevalence of chronic diseases, expanding vaccination programs, and increasing demand for home-based treatments. Additionally, advancements in automatic needle shielding and retractable technologies are enhancing safety and usability, driving steady growth in the region.

4. What are the drivers for the needle safety devices market?

  • The growth of the needle safety devices market is largely attributed to the increasing number of accidental needlestick injuries and the heightened concern over the transmission of blood-borne infections among healthcare professionals. The rising burden of chronic conditions that require repeated injections, along with expanding vaccination initiatives and higher healthcare spending, is further contributing to market expansion. Moreover, the shift toward home healthcare and self-administration of injectable therapies is creating additional demand for safer devices. Continuous innovations in passive and auto-retractable technologies are improving safety, ease of use, and regulatory compliance, thereby driving overall market growth.

5. Who are the key players operating in the needle safety devices market?

  • Some of the key market players operating in the needle safety devices market include BD, Terumo Corporation, Nipro, ICU Medical, B.Braun, Retractable Technologies, AdvaCare Pharma, Medtronic, Hindustan Syringes & Medical Devices Ltd., Cardinal Health, Vygon SA, Gerresheimer AG, West Pharmaceutical Services, Inc., UltiMed, Inc., Argon Medical Devices, Inc., Novo Nordisk A/S, Kindly (KDL) Meditech, Weigao Group, Jiangsu Jichun Medical Devices Co., Ltd., Sarstedt AG & CO. KG and others.

Table of Contents

1. Needle Safety Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Needle Safety Devices Market Executive Summary

  • 2.1 Market at Glance

3. Needle Safety Devices Market Key Factors Analysis

  • 3.1 Needle Safety Devices Market Drivers
    • 3.1.1 Rising incidence of needlestick injuries
    • 3.1.2 Increasing chronic conditions such as diabetes, cancer, autoimmune disorders requiring frequent injections
    • 3.1.3 Increase in vaccination & immunization programs
    • 3.1.4 Growth in self-administration & home healthcare
    • 3.1.5 Increase in product development activities
  • 3.2 Needle Safety Devices Market Restraints and Challenges
    • 3.2.1 Risk of environmental & waste management concerns
    • 3.2.2 Increasing product recalls
    • 3.2.3 Stringent regulatory approval process
  • 3.3 Needle Safety Devices Market Opportunity
    • 3.3.1 Increasing development of passive safety mechanism, retractable needles, dual-safety systems, and smart/connected devices

4. Impact Analysis

  • 4.1 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Needle Safety Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Needle Safety Devices Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Safety Needles
      • 7.1.1.1 Safety Hypodermic Needles
      • 7.1.1.2 Safety Pen Needles
      • 7.1.1.3 Safety Blood Collection Needles
      • 7.1.1.4 Others
    • 7.1.2 Safety Syringes
    • 7.1.3 Safety IV Catheters
  • 7.2 By Safety Mechanism
    • 7.2.1 Active Safety Devices
    • 7.2.2 Passive Safety Devices
  • 7.3 By End-Users
    • 7.3.1 Hospitals & Clinics
    • 7.3.2 Ambulatory Surgical Centers
    • 7.3.3 Homecare Settings
    • 7.3.4 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States Needle Safety Devices Market Size in USD million (2023-2034)
      • 7.4.1.2 Canada Needle Safety Devices Market Size in USD million (2023-2034)
      • 7.4.1.3 Mexico Needle Safety Devices Market Size in USD million (2023-2034)
    • 7.4.2 Europe
      • 7.4.2.1 France Needle Safety Devices Market Size in USD million (2023-2034)
      • 7.4.2.2 Germany Needle Safety Devices Market Size in USD million (2023-2034)
      • 7.4.2.3 United Kingdom Needle Safety Devices Market Size in USD million (2023-2034)
      • 7.4.2.4 Italy Needle Safety Devices Market Size in USD million (2023-2034)
      • 7.4.2.5 Spain Needle Safety Devices Market Size in USD million (2023-2034)
      • 7.4.2.6 Rest of Europe Needle Safety Devices Market Size in USD million (2023-2034)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China Needle Safety Devices Market Size in USD million (2023-2034)
      • 7.4.3.2 Japan Needle Safety Devices Market Size in USD million (2023-2034)
      • 7.4.3.3 India Needle Safety Devices Market Size in USD million (2023-2034)
      • 7.4.3.4 Australia Needle Safety Devices Market Size in USD million (2023-2034)
      • 7.4.3.5 South Korea Needle Safety Devices Market Size in USD million (2023-2034)
      • 7.4.3.6 Rest of Asia-Pacific Needle Safety Devices Market Size in USD million (2023-2034)
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 Middle East Needle Safety Devices Market Size in USD million (2023-2034)
      • 7.4.4.2 Africa Needle Safety Devices Market Size in USD million (2023-2034)
      • 7.4.4.3 South America Needle Safety Devices Market Size In USD Million (2023-2034)

8. Competitive Landscape

9. Needle Safety Devices Market Company and Product Profiles

  • 9.1 BD
    • 9.1.1 Company Overview
    • 9.1.2 Company Snapshot
    • 9.1.3 Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5 Entropy
  • 9.2 Terumo Corporation
    • 9.2.1 Company Overview
    • 9.2.2 Company Snapshot
    • 9.2.3 Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5 Entropy
  • 9.3 Nipro
    • 9.3.1 Company Overview
    • 9.3.2 Company Snapshot
    • 9.3.3 Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5 Entropy
  • 9.4 ICU Medical
    • 9.4.1 Company Overview
    • 9.4.2 Company Snapshot
    • 9.4.3 Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5 Entropy
  • 9.5 B.Braun SE
    • 9.5.1 Company Overview
    • 9.5.2 Company Snapshot
    • 9.5.3 Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5 Entropy
  • 9.6 Retractable Technologies, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Company Snapshot
    • 9.6.3 Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5 Entropy
  • 9.7 AdvaCare Pharma
    • 9.7.1 Company Overview
    • 9.7.2 Company Snapshot
    • 9.7.3 Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5 Entropy
  • 9.8 Medtronic
    • 9.8.1 Company Overview
    • 9.8.2 Company Snapshot
    • 9.8.3 Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5 Entropy
  • 9.9 Hindustan Syringes & Medical Devices Ltd.
    • 9.9.1 Company Overview
    • 9.9.2 Company Snapshot
    • 9.9.3 Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5 Entropy
  • 9.10 Cardinal Health
    • 9.10.1 Company Overview
    • 9.10.2 Company Snapshot
    • 9.10.3 Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5 Entropy
  • 9.11 Vygon SA
    • 9.11.1 Company Overview
    • 9.11.2 Company Snapshot
    • 9.11.3 Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5 Entropy
  • 9.12 Gerresheimer AG
    • 9.12.1 Company Overview
    • 9.12.2 Company Snapshot
    • 9.12.3 Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5 Entropy
  • 9.13 West Pharmaceutical Services, Inc.
    • 9.13.1 Company Overview
    • 9.13.2 Company Snapshot
    • 9.13.3 Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5 Entropy
  • 9.14 UltiMed, Inc.
    • 9.14.1 Company Overview
    • 9.14.2 Company Snapshot
    • 9.14.3 Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5 Entropy
  • 9.15 Argon Medical Devices, Inc.
    • 9.15.1 Company Overview
    • 9.15.2 Company Snapshot
    • 9.15.3 Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5 Entropy
  • 9.16 Novo Nordisk A/S
    • 9.16.1 Company Overview
    • 9.16.2 Company Snapshot
    • 9.16.3 Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5 Entropy
  • 9.17 Kindly (KDL) Meditech
    • 9.17.1 Company Overview
    • 9.17.2 Company Snapshot
    • 9.17.3 Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5 Entropy
  • 9.18 Weigao Group
    • 9.18.1 Company Overview
    • 9.18.2 Company Snapshot
    • 9.18.3 Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5 Entropy
  • 9.19 Jiangsu Jichun Medical Devices Co., Ltd.
    • 9.19.1 Company Overview
    • 9.19.2 Company Snapshot
    • 9.19.3 Financial Overview
    • 9.19.4 Product Listing
    • 9.19.5 Entropy
  • 9.20 Sarstedt AG& Co. KG
    • 9.20.1 Company Overview
    • 9.20.2 Company Snapshot
    • 9.20.3 Financial Overview
    • 9.20.4 Product Listing
    • 9.20.5 Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1: Needle Safety Devices Market in Global (2023-2034)
  • Table 2: Needle Safety Devices Market in Global by Product Type (2023-2034)
  • Table 3: Needle Safety DevicesMarket in Global by Safety Mechanism (2023-2034)
  • Table 4: Needle Safety Devices Market in Global by End-Users (2023-2034)
  • Table 5: Needle Safety Devices Market in Global by Geography (2023-2034)
  • Table 6: Needle Safety Devices Market in North America (2023-2034)
  • Table 7: Needle Safety Devices Market in the United States (2023-2034)
  • Table 8: Needle Safety Devices Market in Canada (2023-2034)
  • Table 9: Needle Safety Devices Market in Mexico (2023-2034)
  • Table 10: Needle Safety Devices Market in Europe (2023-2034)
  • Table 11: Needle Safety Devices Market in France (2023-2034)
  • Table 12: Needle Safety Devices Market in Germany (2023-2034)
  • Table 13: Needle Safety Devices Market in United Kingdom (2023-2034)
  • Table 14: Needle Safety Devices Market in Italy (2023-2034)
  • Table 15: Needle Safety Devices Market in Spain (2023-2034)
  • Table 16: Needle Safety Devices Market in the Rest of Europe (2023-2034)
  • Table 17: Needle Safety Devices Market in Asia-Pacific (2023-2034)
  • Table 18: Needle Safety Devices Market in China (2023-2034)
  • Table 19: Needle Safety Devices Market in Japan (2023-2034)
  • Table 20: Needle Safety Devices Market in India (2023-2034)
  • Table 21: Needle Safety Devices Market in Australia (2023-2034)
  • Table 22: Needle Safety Devices Market in South Korea (2023-2034)
  • Table 23: Needle Safety Devices Market in Rest of Asia-Pacific (2023-2034)
  • Table 24: Needle Safety Devices Market in the Rest of the World (2023-2034)
  • Table 25: Needle Safety Devices Market in the Middle East (2023-2034)
  • Table 26: Needle Safety Devices Market in Africa (2023-2034)
  • Table 27: Needle Safety Devices Market in South America (2023-2034)
  • Table 28: Competitive Landscape

List of Figures

  • Figure 1: Needle Safety Devices Market Drivers
  • Figure 2: Needle Safety Devices Market Restraints
  • Figure 3: Needle Safety Devices Market Opportunities
  • Figure 4: AI-Powered Innovations in Needle Safety Devices Market
  • Figure 5: US Tariff Impact on Needle Safety Devices Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Needle Safety Devices Market in Global (2023-2034)
  • Figure 10: Needle Safety Devices Market in Global by Product Type (2023-2034)
  • Figure 11: Needle Safety Devices Market in Global by Safety Mechanism (2023-2034)
  • Figure 12: Needle Safety Devices Market in Global by End-Users (2023-2034)
  • Figure 13: Needle Safety Devices Market in Global by Geography (2023-2034)
  • Figure 14: Needle Safety Devices Market in North America (2023-2034)
  • Figure 15: Needle Safety Devices Market in the United States (2023-2034)
  • Figure 16: Needle Safety Devices Market in Canada (2023-2034)
  • Figure 17: Needle Safety Devices Market in Mexico (2023-2034)
  • Figure 18: Needle Safety Devices Market in Europe (2023-2034)
  • Figure 19: Needle Safety Devices Market in France (2023-2034)
  • Figure 20: Needle Safety Devices Market in Germany (2023-2034)
  • Figure 21: Needle Safety Devices Market in United Kingdom (2023-2034)
  • Figure 22: Needle Safety Devices Market in Italy (2023-2034)
  • Figure 23: Needle Safety Devices Market in Spain (2023-2034)
  • Figure 24: Needle Safety Devices Market in the Rest of Europe (2023-2034)
  • Figure 25: Needle Safety Devices Market in Asia-Pacific (2023-2034)
  • Figure 26: Needle Safety Devices Market in China (2023-2034)
  • Figure 27: Needle Safety Devices Market in Japan (2023-2034)
  • Figure 28: Needle Safety Devices Market in India (2023-2034)
  • Figure 29: Needle Safety Devices Market in Australia (2023-2034)
  • Figure 30: Needle Safety Devices Market in South Korea (2023-2034)
  • Figure 31: Needle Safety Devices Market in Rest of Asia-Pacific (2023-2034)
  • Figure 32: Needle Safety Devices Market in the Rest of the World (2023-2034)
  • Figure 33: Needle Safety Devices Market in the Middle East (2023-2034)
  • Figure 34: Needle Safety Devices Market in Africa (2023-2034)
  • Figure 35: Needle Safety Devices Market in South America (2023-2034)
  • Figure 36: Competitive Landscape